[1] [1] FLETCHER H A, SCHRAGER L. TB vaccine development and the End TB Strategy: importance and current status [J].Trans R Soc Trop Med Hyg, 2016,110(4): 212-218.

[2] [2] WHO. Global tuberculosis report 2023 [EB/OL]. (2023-11-07)[2024-07-10]. https://www.who.int/teams/globaltuberculosis-programme/tb-reports/global-tuberculosisreport-2023.

[3] [3] SINGH V, CHIBALE K. Strategies to combat multi-drug resistance in tuberculosis [J].Acc Chem Res, 2021,54(10): 2361-2376.

[4] [4] REWARI B B, KUMAR A, MANDAL P P,et al. HIV TB coinfection - perspectives from India [J].Expert Rev Respir Med, 2021,15(7): 911-930.

[5] [5] TUNESI S, D D L, GUALANO G,et al. Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: a TBnet and ESGMYC study [J].J Infect, 2022,84(6): 834-872.

[6] [6] QU M J, ZHOU X M, LI H,et al. BCG vaccination strategies against tuberculosis: updates and perspectives [J].Hum Vaccin Immunother, 2021,17(12): 5284-5295.

[7] [7] BO H T, MOURE U A E, YANG Y M,et al.Mycobacterium tuberculosis-macrophage interaction: molecular updates [J].Front Cell Infect Microbiol, 2023,13: 1062963.

[8] [8] MATA E, TARANCON R, GUERRERO C,et al. Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis [J].Sci Immunol, 2021,6(63): eabc2934.

[10] [10] ABDALLA A E, YAN S, ZENG J,et al.Mycobacterium tuberculosis Rv0341promotesMycobacteriumsurvival inin vitrohostile environments and within macrophages and induces cytokines expression [J].Pathogens, 2020,9(6): 437.

[11] [11] ROXO C, KOTKOWIAK W, PASTERNAK A. G-quadruplex-forming aptamers-characteristics, applications, and perspectives [J].Molecules, 2019,24(20): 3781.

[12] [12] HONISCH C, RAGAZZI E, HUSSAIN R,et al. Interaction of a short peptide with G-quadruplex-forming sequences: an SRCD and CD study [J].Pharmaceutics, 2021,13(8): 1104.

[15] [15] LI C H, WANG H H, YIN Z N,et al. Ligand-induced native G-quadruplex stabilization impairs transcription initiation [J].Genome Res, 2021,31(9): 1546-1560.

[16] [16] DINH V T, LOAC N, QUILLVR A,et al. The hide-and-seek game of the oncogenic Epstein-Barr virusencoded EBNA1 protein with the immune system: an RNA G-quadruplex tale [J].Biochimie, 2023,214(Pt A): 57-68.

[17] [17] HORSBURGH B C, KOLLMUS H, HAUSER H,et al. Translational recoding induced by G-rich mRNA sequences that form unusual structures [J].Cell, 1996,86(6): 949-959.

[18] [18] HARRIS L M, MERRICK C J. G-quadruplexes in pathogens: a common route to virulence control? [J].PLoS Pathog, 2015,11(2): e1004562.

[19] [19] SHANMUGANATHAN G, ORUJYAN D, NARINYAN W,et al. Role of interferons inMycobacterium tuberculosisinfection [J].Clin Pract, 2022,12(5): 788-796.

[20] [20] WIK J A, SKLHEGG B S. T cell metabolism in infection[J].Front Immunol, 2022,13: 840610.

[21] [21] BEDARD M, VAN DER NIET S, BERNARD E M,et al. A terpene nucleoside fromM.tuberculosisinduces lysosomal lipid storage in foamy macrophages [J].J Clin Invest, 2023,133(6): e161944.

[22] [22] BIAN W X, XIE Y, WANG X N,et al. Binding of cellular nucleolin with the viral core RNA G-quadruplex structure suppresses HCV replication [J].Nucleic Acids Res, 2019,47(1): 56-68.

[23] [23] DAVID A P, PIPIER A, PASCUTTI F,et al. CNBP controls transcription by unfolding DNA G-quadruplex structures [J].Nucleic Acids Res, 2019,47(15): 7901-7913.